111 related articles for article (PubMed ID: 1463787)
1. Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography.
Renn O; Meares CF
Bioconjug Chem; 1992; 3(6):563-9. PubMed ID: 1463787
[TBL] [Abstract][Full Text] [Related]
2. Improved synthesis of 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N",N"-tetraacetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents.
Moran JK; Greiner DP; Meares CF
Bioconjug Chem; 1995; 6(3):296-301. PubMed ID: 7632802
[TBL] [Abstract][Full Text] [Related]
3. Stable bifunctional chelates of metals used in radiotherapy.
Moi MK; DeNardo SJ; Meares CF
Cancer Res; 1990 Feb; 50(3 Suppl):789s-793s. PubMed ID: 2297725
[TBL] [Abstract][Full Text] [Related]
4. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
Chappell LL; Rogers BE; Khazaeli MB; Mayo MS; Buchsbaum DJ; Brechbiel MW
Bioorg Med Chem; 1999 Nov; 7(11):2313-20. PubMed ID: 10632041
[TBL] [Abstract][Full Text] [Related]
5. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.
McCall MJ; Diril H; Meares CF
Bioconjug Chem; 1990; 1(3):222-6. PubMed ID: 2096914
[TBL] [Abstract][Full Text] [Related]
6. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic chelates of radiometals for diagnosis and therapy.
Meares CF; Moi MK; Diril H; Kukis DL; McCall MJ; Deshpande SV; DeNardo SJ; Snook D; Epenetos AA
Br J Cancer Suppl; 1990 Jul; 10():21-6. PubMed ID: 2383477
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates.
Somayaji VV; Guay V; Peng Z; Sykes TR; Noujaim AA
Q J Nucl Med; 1995 Dec; 39(4):300-10. PubMed ID: 8624793
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of two new bifunctional carboxymethylated tetraazamacrocyclic chelating agents for protein labeling with indium-111.
Ruser G; Ritter W; Maecke HR
Bioconjug Chem; 1990; 1(5):345-9. PubMed ID: 2098112
[TBL] [Abstract][Full Text] [Related]
10. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
[TBL] [Abstract][Full Text] [Related]
11. Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.
Peterson JJ; Pak RH; Meares CF
Bioconjug Chem; 1999; 10(2):316-20. PubMed ID: 10077483
[TBL] [Abstract][Full Text] [Related]
12. Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates.
Dadachova E; Chappell LL; Brechbiel MW
Nucl Med Biol; 1999 Nov; 26(8):977-82. PubMed ID: 10708314
[TBL] [Abstract][Full Text] [Related]
13. Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.
Moi MK; Meares CF; McCall MJ; Cole WC; DeNardo SJ
Anal Biochem; 1985 Jul; 148(1):249-53. PubMed ID: 4037304
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-(p-thiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid: application of the 4-methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines.
McMurry TJ; Brechbiel M; Wu C; Gansow OA
Bioconjug Chem; 1993; 4(3):236-45. PubMed ID: 8324015
[TBL] [Abstract][Full Text] [Related]
15. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
Kukis DL; DeNardo SJ; DeNardo GL; O'Donnell RT; Meares CF
J Nucl Med; 1998 Dec; 39(12):2105-10. PubMed ID: 9867151
[TBL] [Abstract][Full Text] [Related]
16. Carboxymethyl-substituted bifunctional chelators: preparation of aryl isothiocyanate derivatives of 3-(carboxymethyl)-3-azapentanedioic acid, 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic++ + acid, and 1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid for use as protein labels.
Kline SJ; Betebenner DA; Johnson DK
Bioconjug Chem; 1991; 2(1):26-31. PubMed ID: 1908704
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates.
Li M; Meares CF
Bioconjug Chem; 1993; 4(4):275-83. PubMed ID: 8218484
[TBL] [Abstract][Full Text] [Related]
18. Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds.
Wängler C; Wängler B; Eisenhut M; Haberkorn U; Mier W
Bioorg Med Chem; 2008 Mar; 16(5):2606-16. PubMed ID: 18065226
[TBL] [Abstract][Full Text] [Related]
19. A convenient synthesis of bifunctional chelating agents based on diethylenetriaminepentaacetic acid and their coordination chemistry with yttrium(III).
Cummins CH; Rutter EW; Fordyce WA
Bioconjug Chem; 1991; 2(3):180-6. PubMed ID: 1932217
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
Williams LE; Lewis MR; Bebb GG; Clarke KG; Odom-Maryon TL; Shively JE; Raubitschek AA
Bioconjug Chem; 1998; 9(1):87-93. PubMed ID: 9460550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
